Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Navarro

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Annals of Hematology|May 1, 2014
Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experienceA García-Noblejas, C Martínez Chamorro, B Navarro Matilla, et al.
Leukemia|January 9, 2013
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcomeN Villamor, L Conde, A Martínez-Trillos, et al.
Actas Dermo-Sifiliograficas|September 9, 2023
Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease StageB Navarro Matilla, P L Ortiz Romero, R M Pujol Vallverdú, et al.
Actas Dermo-Sifiliograficas|December 4, 2023
[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease StageB Navarro Matilla, P L Ortiz Romero, R M Pujol Vallverdú, et al.
Nature Genetics|October 23, 2023
Post-zygotic rescue of meiotic errors causes brain mosaicism and focal epilepsyKatherine E Miller, Adithe C Rivaldi, Noriyuki Shinagawa, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Plant Disease|January 2, 2025
Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from RegulationI E Tzanetakis, V Aknadibossian, J Špak, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Annals of Hematology|May 1, 2014
Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experienceA García-Noblejas, C Martínez Chamorro, B Navarro Matilla, et al.
Leukemia|January 9, 2013
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcomeN Villamor, L Conde, A Martínez-Trillos, et al.
Actas Dermo-Sifiliograficas|September 9, 2023
Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease StageB Navarro Matilla, P L Ortiz Romero, R M Pujol Vallverdú, et al.
Actas Dermo-Sifiliograficas|December 4, 2023
[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease StageB Navarro Matilla, P L Ortiz Romero, R M Pujol Vallverdú, et al.
Nature Genetics|October 23, 2023
Post-zygotic rescue of meiotic errors causes brain mosaicism and focal epilepsyKatherine E Miller, Adithe C Rivaldi, Noriyuki Shinagawa, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Plant Disease|January 2, 2025
Streamlining Global Germplasm Exchange: Integrating Scientific Rigor and Common Sense to Exclude Phantom Agents from RegulationI E Tzanetakis, V Aknadibossian, J Špak, et al.
Pageof 17